Consolidated Biosciences ApS: Financial statements 2025
CVR: 40180230
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Consolidated Biosciences ApS (CVR 40180230) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -52,501 and a net result of DKK -1,814,488 compared with DKK -1,740,301 the year before. Equity in the 2025 report amounted to DKK 202,862. The solvency ratio was 0.1%.
- Gross Profit
- DKK -52,501
- Profit/Loss
- DKK -1,814,488
- Equity
- DKK 202,862
- Total Assets
- DKK 136,386,007
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -53K | -1.8M | 203K | 0 |
| 2024 | - | -49K | -1.7M | 2M | - |
| 2023 | - | -54K | -1.7M | 1.3M | - |
| 2022 | - | -46K | -1M | 3M | - |
| 2021 | - | -34K | -1.1M | -1M | - |
Official annual report
How creditworthy is Consolidated Biosciences ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Consolidated Biosciences ApS has published its annual report for 2024. Gross profit came to DKK -49,125, and the net result was DKK -1,740,301.
About Consolidated Biosciences ApS
Consolidated Biosciences ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2019. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Lone Schøtt Kunøe. The company is owned by CENTRAL EUROPEAN FOOD PRODUCTION COMPANY ApS, CONSOLIDATED HOLDINGS A/S and L1 HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,501 and a net result of DKK -1,814,488 compared with DKK -1,740,301 the year before. Equity in the 2025 report amounted to DKK 202,862.